PortfoliosLab logo
Viemed Healthcare Inc (VMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA92663R1055

CUSIP

92663R105

IPO Date

Dec 22, 2017

Highlights

Market Cap

$249.79M

EPS (TTM)

$0.28

PE Ratio

22.57

Total Revenue (TTM)

$173.66M

Gross Profit (TTM)

$103.02M

EBITDA (TTM)

$35.45M

Year Range

$6.14 - $7.58

Target Price

$12.83

Short %

0.93%

Short Ratio

2.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period


VMD

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

5.53%

6M

-5.60%

1Y

8.37%

5Y*

14.61%

10Y*

10.35%

*Annualized

Monthly Returns

The table below presents the monthly returns of VMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-13.78%-13.78%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of VMD is 25, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of VMD is 2525
Overall Rank
The Sharpe Ratio Rank of VMD is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of VMD is 2323
Sortino Ratio Rank
The Omega Ratio Rank of VMD is 2525
Omega Ratio Rank
The Calmar Ratio Rank of VMD is 2727
Calmar Ratio Rank
The Martin Ratio Rank of VMD is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Viemed Healthcare Inc. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Dividends

Dividend History


Viemed Healthcare Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Viemed Healthcare Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Viemed Healthcare Inc was 14.59%, occurring on May 9, 2025. The portfolio has not yet recovered.

The current Viemed Healthcare Inc drawdown is 14.59%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-14.59%May 7, 20253May 9, 2025

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Viemed Healthcare Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Viemed Healthcare Inc, comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.


0.000.100.200.300.400.5020212022202320242025
0.06
0.06
Actual
Estimate

Valuation

The Valuation section provides an overview of how Viemed Healthcare Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for VMD, comparing it with other companies in the Medical Devices industry. Currently, VMD has a P/E ratio of 22.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VMD relative to other companies in the Medical Devices industry. Currently, VMD has a P/S ratio of 1.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VMD in comparison with other companies in the Medical Devices industry. Currently, VMD has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items